CAS: 1004757-96-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide REF: 3D-EQB75796CAS: 1004757-96-3 | Min. 95% | To inquire | Mon 17 Jun 24 |
![N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide](https://static.cymitquimica.com/products/3D/thumb/EQB75796.jpg)
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
CAS:1004757-96-3
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide (NAPQI) is a new drug that is being developed for the treatment of autoimmune …
Formula:
C25H33F3N6O2
Purity:
Min. 95%
Molecular weight:
506.6 g/mol
Ref: 3D-EQB75796
| 100mg | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024
